RxDoctor Payments Data

Frederick Fisher, MD

Pain Medicine · Dakota Dunes, SDNPI 1841211471

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (52.0%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Abbott at 43.4% of the total.

$4,239in general payments, 2019–2025

Across 82 payments — averaging $51.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Si-bone, Inc.$1K
  • Boston Scientific$259
  • Genesys Orthopedics Systems, L.L.C.$175
  • Riwospine, Inc.$148
  • Relievant Medsystems, Inc.$147
  • plus $655 from 16 others

What the payments were for

  • Travel & lodging$2,20552%
  • Food & beverage$1,86044%
  • Gifts$1754%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pain medicine providers in South Dakotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$139,619
Medicare patients
290
Services billed
6,198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant12$12,613
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen180$5,159
Morphine Sulfate ErMorphine Sulfate80$2,461
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen43$984
Tramadol Hcl68$680
Oxycodone Hcl23$596
Methadone Hcl21$363
Gabapentin14$137
Cyclobenzaprine Hcl20$112
Tizanidine Hcl28$88

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy$141$12,61312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few pain medicine providers in South Dakotaon file to place this against a meaningful peer group, so we don't.

Other pain medicine in Dakota Dunes

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →